Molecular Devices
CA - San jose
CYPROHEPTADINE HYDROCHLORIDE (cyproheptadine hydrochloride) by Molecular Devices is clinical pharmacology: cyproheptadine hci is a serotonin and histamine antagonist with anticholinergic and sedative effects. First approved in 1983.
Drug data last refreshed 20h ago
CLINICAL PHARMACOLOGY: Cyproheptadine HCI is a serotonin and histamine antagonist with anticholinergic and sedative effects. Antiserotonin and antihistamine drugs appears to compete with serotonin and histamine, respectively, for receptor sites. Pharmacokinetics and Metabolism: After a single 4 mg…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on CYPROHEPTADINE HYDROCHLORIDE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.